Biology · 11th Grade · Information Storage and Transfer · Weeks 1-9

Cancer: Uncontrolled Cell Growth

Investigates the molecular basis of cancer, including mutations in proto-oncogenes and tumor suppressor genes, and the characteristics of cancer cells.

• Common Core State Standards
• HS-LS1-4

About This Topic

Cancer is fundamentally a disease of cell cycle regulation failure, caused by the accumulation of mutations in genes that control cell division. Proto-oncogenes normally promote cell division in response to appropriate signals; when mutated into oncogenes, they drive continuous division regardless of external signals. Tumor suppressor genes like p53 and Rb normally apply the brakes to the cell cycle; loss-of-function mutations in these genes remove critical checkpoints, allowing damaged cells to divide unchecked.

Cancer cells display a distinct set of characteristics: they ignore growth inhibition signals, sustain their own growth signals, evade apoptosis (programmed cell death), replicate without limit, promote angiogenesis (blood vessel growth), and eventually invade other tissues through metastasis. These hallmarks, originally described by Hanahan and Weinberg, give students a systematic framework for connecting cellular mechanisms to clinical observations.

For 11th-grade US biology students, cancer is not abstract , most have been touched by it personally or through family. Making the molecular biology of cancer accessible requires connecting cellular mechanisms to clinical realities. Active learning tasks that require students to reason from molecular evidence to patient outcomes are particularly powerful for this topic.

Key Questions

1. Explain how mutations in specific genes can lead to uncontrolled cell proliferation.
2. Analyze the distinguishing characteristics of cancer cells compared to normal cells.
3. Evaluate the challenges in developing effective treatments for various types of cancer.

Learning Objectives

• Analyze the molecular mechanisms by which mutations in proto-oncogenes and tumor suppressor genes lead to uncontrolled cell proliferation.
• Compare and contrast the characteristic behaviors of cancer cells (e.g., sustained proliferation, evasion of growth suppressors) with those of normal cells.
• Evaluate the scientific rationale behind current cancer treatment strategies, considering the challenges posed by cancer cell heterogeneity and evolution.
• Explain how the loss of cell cycle checkpoints contributes to the accumulation of genetic damage in cancer cells.

Before You Start

Cell Cycle Regulation

Why: Students must understand the normal checkpoints and regulatory proteins of the cell cycle to grasp how their failure leads to cancer.

Introduction to Genetics and Gene Expression

Why: Understanding basic gene function, mutation, and protein synthesis is essential for comprehending how altered genes cause disease.

Key Vocabulary

Proto-oncogene	A normal gene that can become an oncogene if it mutates or is rearranged, potentially contributing to cancer development by promoting cell growth.
Oncogene	A gene that has the potential to cause cancer. Oncogenes are typically mutated or activated proto-oncogenes that drive uncontrolled cell division.
Tumor suppressor gene	A gene that protects a cell from becoming cancerous. When mutated or inactivated, these genes can allow cells to grow and divide uncontrollably.
Apoptosis	Programmed cell death, a normal process that eliminates damaged or unnecessary cells. Cancer cells often evade apoptosis.
Angiogenesis	The formation of new blood vessels. Tumors require angiogenesis to grow beyond a small size by supplying them with oxygen and nutrients.
Metastasis	The spread of cancer cells from the place where they first formed to another part of the body. This is a hallmark of advanced cancer.

Watch Out for These Misconceptions

Common Misconception

Cancer is caused by a single mutation.

What to Teach Instead

Cancer development is typically multistep, requiring accumulation of several mutations over time , usually in both oncogenes and tumor suppressors. A single mutation rarely produces cancer because remaining checkpoints continue to function. The multi-hit model helps students interpret why cancer risk increases with age and prolonged mutagen exposure.

Common Misconception

Cancer is always inherited.

What to Teach Instead

Most cancers result from somatic mutations acquired during a person's lifetime, not inherited germline mutations. Inherited cancer syndromes (like BRCA1/2) increase risk by reducing the additional mutations needed, but they represent a minority of cases. This distinction helps students reason about risk factors without implying genetic determinism.

Active Learning Ideas

Inquiry Circle: Hallmarks of Cancer Case Study

Groups receive a clinical case , such as a lung cancer patient's biopsy and genomic data , and identify which hallmarks of cancer are present, propose which proto-oncogene or tumor suppressor is likely affected, and explain how each molecular change produces the observed tumor behavior. Groups present and debate their analyses.

50 min·Small Groups

Think-Pair-Share: Oncogene vs. Tumor Suppressor

Students independently categorize a list of gene descriptions as either proto-oncogene/oncogene or tumor suppressor, then discuss with a partner where they disagreed. The class builds a two-column comparison emphasizing gain-of-function (oncogene) versus loss-of-function (tumor suppressor) mechanisms.

20 min·Pairs

Gallery Walk: Cancer Treatments and Their Molecular Targets

Stations cover chemotherapy (general DNA damage), targeted therapy (e.g., imatinib targeting BCR-ABL), immunotherapy (checkpoint inhibitors), and radiation therapy. Students annotate each station with what molecular mechanism is being targeted, why it is effective, and one potential limitation or side effect.

40 min·Small Groups

Real-World Connections

• Genetic counselors at cancer treatment centers explain to patients how specific gene mutations, like BRCA1 or TP53, increase cancer risk and influence treatment options.
• Researchers at the National Cancer Institute develop targeted therapies that inhibit specific oncogenes, such as imatinib (Gleevec) for chronic myeloid leukemia, by blocking the abnormal protein's activity.

Assessment Ideas

Quick Check

Provide students with a short case study of a patient diagnosed with a specific cancer. Ask them to identify which hallmark of cancer is most evident in the initial symptoms and explain how a specific gene mutation (e.g., in Rb or Ras) could contribute to that hallmark.

Discussion Prompt

Pose the question: 'If cancer is caused by mutations, why are some treatments effective for a while but then stop working?' Guide students to discuss cancer cell evolution, the development of resistance, and the concept of tumor heterogeneity.

Exit Ticket

On one side of an index card, students write the definition of a tumor suppressor gene. On the other side, they write one sentence explaining why a mutation that inactivates a tumor suppressor gene is considered a 'loss-of-function' mutation.

Frequently Asked Questions

What is the difference between an oncogene and a tumor suppressor gene?

An oncogene is a mutated proto-oncogene that is permanently active, driving cell division without appropriate signals. A tumor suppressor gene normally restrains cell division; mutations that inactivate it remove a critical brake on the cycle. Cancer typically requires mutations in both types to fully override the cell's regulatory systems.

Why is p53 called the guardian of the genome?

p53 is a tumor suppressor protein that responds to DNA damage by halting the cell cycle (allowing repair) or triggering apoptosis (preventing a damaged cell from dividing). When p53 is mutated , as in roughly half of human cancers , damaged cells survive and continue accumulating further mutations.

What active learning strategies work best for teaching cancer biology?

Case study analysis using the hallmarks of cancer framework is highly effective. Students apply each hallmark to a real patient case, connecting molecular mutations to tumor behavior. This mirrors how oncologists reason clinically and gives students practice with evidence-based argumentation in a personally meaningful context.

How does cancer spread to other parts of the body?

Cancer spreads through metastasis , a multi-step process in which tumor cells detach from the primary tumor, invade surrounding tissue, enter blood or lymphatic vessels, survive transport, and establish new tumors at distant sites. Metastatic cancer is significantly harder to treat because it cannot be addressed by removing a single localized tumor.